Signal Desk · Companies

Gland Pharma Limited reports a change in its board or management

2026-11-20 · 1 source · Signal Desk Analysis

In short

Gland Pharma Limited said Mr Ajay Sahni has been appointed President of Phixen SAS, its wholly-owned step-down subsidiary, effective November 30, 2026. In simple terms, Gland Pharma is putting a new leader in charge of Phixen SAS. No figures, scheme names, or closing dates are given in the announcement.

Why it matters

A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.

Touches: GLAND, Companies

Sources